Issued and Allowed Patents as of February 06, 2002 Patent # Title Country Inventors Date Filed Date Issued 1,340,513 Antitumor & Antiviral Alkaloids Canada S.Gunasekera, Cross 6/21/88 4/27/99 5,073,572 Bioactive Metabolites from Cribrochalina vasculum US S.Gunasekera, Faircloth, Wright, Thompson, Burres 2/16/90 12/17/91 4,970,226 Novel Antitumor & Antimicrobial Alkaloids US McCarthy, S. Gunasekera, Kashman, Sun, Sakemi, Lui, Burres 10/3/89 11/13/90 5,182,287 Novel Bioactive Heterocycle Alkaloids & Methods of Use US Gunawardana, McCarthy, Burres 8/20/91 1/26/93 5,051,519 Novel Antiviral & Antitumor Terpene Hydroquinones & Methods of Use US Wright, Cross, Burres, Koehn 2/16/90 9/24/91 5,091,412 Novel Antiviral & Antitumor Terpene Hydroquinones & Methods of Use US Wright, Cross, Burres, Koehn 7/6/90 2/25/92 5,204,367 Novel Antiviral & Antitumor Terpene Hydroquinones & Methods of Use US Wright, Cross, Burres, Koehn 12/5/91 4/20/93 5,028,613 Pyrroloquinoline Alkaloids & Methods of Use US Sun, Sakmei 2/16/90 7/2/91 5,091,368 Biologically Active Compounds from Blue-green Algae US Koehn, Longley, Cross 8/8/90 2/25/92 FR0542891 Biologically Active Compounds From Blue-Green Algae France Koehn, Longley, Cross 8/5/91 1/18/95 P69106877.1 Biologically Active Compounds From Blue-Green Algae Germany Koehn, Longley, Cross 8/5/91 1/18/95 GB054 891 Biologically Active Compounds From Blue-Green Algae Great Britain Koehn, Longley, Cross 8/5/91 1/18/95 IT0542891 Biologically Active Compounds From Blue-Green Algae Italy Koehn, Longley, Cross 8/5/91 1/18/95 ES0542891 Biologically Active Compounds From Blue-Green Algae Spain Koehn, Longley, Cross 8/5/91 1/18/95 P0542891 Biologically Active Compounds From Blue-Green Algae Switzerland Koehn, Longley, Cross 8/5/91 1/18/95 5,059,618 Novel Bioactive Discodermides & Methods of Use US S.Gunasekera, M.Gunasekera, McCarthy 7/6/90 10/22/91 5,336,757 Novel Antitumor & Antibacterial Peptide & Methods of Use US Gulavita, S.Gunasekera, Pomponi, Longley, McCarthy 2/4/92 8/9/94 5,516,755 Novel Antitumor & Antibacterial Peptide & Methods of Use US Gulavita, S.Gunasekera, Pomponi, Longley, McCarthy 8/8/94 5/14/96 5,290,777 Novel Use for Bis-indole Compounds & Pharmaceutical Compositions containing same US McConnell, Saucy, Jacobs 2/24/93 3/1/94 5,464,835 Novel Use for Bis-Heterocyclic Compounds & Pharmaceutical Compositions Containing Same US McConnell, Saucy, Jacobs, S.Gunasekera 2/24/94 11/7/95 5,496,950 Novel Use for Bis-heterocyclic compounds and pharmaceutical compositions containing same. US McConnell, Saucy, Jacobs, S.Gunasekera 10/28/94 3/5/96 FR0686154 Novel Use as Anti-Inflammatory Agents for Bis-heterocycle Compounds and Pharmaceutical Compositions Thereof France McConnell, Saucy, Jacobs, S.Gunasekera 2/24/94 4/22/98 69409796.900000006 Novel Use as Anti-Inflammatory Agents for Bis-heterocycle Compounds and Pharmaceutical Compositions Thereof Germany McConnell, Saucy, Jacobs, S.Gunasekera 2/24/94 4/22/98 GB0686154 Novel Use as Anti-Inflammatory Agents for Bis-heterocycle Compounds and Pharmaceutical Compositions Thereof Great Britain McConnell, Saucy, Jacobs, S.Gunasekera 2/24/94 4/22/98 IT0686154 Novel Use as Anti-Inflammatory Agents for Bis-heterocycle Compounds and Pharmaceutical Compositions Thereof Italy McConnell, Saucy, Jacobs, S.Gunasekera 2/24/94 4/22/98 ES0686154 Novel Use as Anti-Inflammatory Agents for Bis-heterocycle Compounds and Pharmaceutical Compositions Thereof Spain McConnell, Saucy, Jacobs, S.Gunasekera 2/24/94 4/22/98 PO686154 Novel Use as Anti-Inflammatory Agents for Bis-heterocycle Compounds and Pharmaceutical Compositions Thereof Switzerland McConnell, Saucy, Jacobs, S.Gunasekera 2/24/98 4/22/99 5,298,523 Immunomodulatory Uses of Mycalamide Compounds US Longley, Faircloth 12/14/92 3/29/94 5,478,861 Novel Cytotoxic Macrolides and Methods of Use US Horton, Koehn, Longley, McConnell, Pomponi 2/18/94 12/26/95 5,684,036 Novel Cytotoxic Macrolides and Methods for Use US Horton, Koehn, Longley, McConnell, Pomponi 6/7/95 11/4/97 PAGE 1 • PAGE 2 • PAGE 3 • PAGE 4 • Home   • Programs & Facilities   • Recent Missions   • Patents   • Staff Profiles   • Contact DBMR